Catalyst Pharmaceuticals (CPRX) Revenue (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.11% |
| Dec 31, 2025 | 2.84% |
| Sep 30, 2025 | 1.25% |
| Jun 30, 2025 | 3.64% |
| Mar 31, 2025 | -0.28% |
| Dec 31, 2024 | 10.20% |
| Sep 30, 2024 | 4.88% |
| Jun 30, 2024 | 24.57% |
| Mar 31, 2024 | -10.91% |
| Dec 31, 2023 | 7.67% |
| Sep 30, 2023 | 3.12% |
| Jun 30, 2023 | 16.65% |
| Mar 31, 2023 | 40.50% |
| Dec 31, 2022 | 6.14% |
| Sep 30, 2022 | 7.78% |
| Jun 30, 2022 | 23.26% |
| Mar 31, 2022 | 12.48% |
| Dec 31, 2021 | 6.55% |
| Sep 30, 2021 | -1.13% |
| Jun 30, 2021 | 20.39% |
| Mar 31, 2021 | -2.61% |
| Dec 31, 2020 | 5.79% |
| Sep 30, 2020 | -0.97% |
| Jun 30, 2020 | 1.61% |
| Mar 31, 2020 | -3.27% |
| Dec 31, 2019 | -2.51% |
| Sep 30, 2019 | 7.14% |
| Jun 30, 2019 | 131.66% |
| Mar 31, 2019 | 2,389.69% |